Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-195/miR-497 RegulateCD274Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer

1 Jan 2018

Abstract excerpt

PURPOSE: Immune suppression is common in patients with advanced breast cancer but the mechanisms underlying this phenomenon have not been sufficiently studied. In this study, we aimed to identify B7 family members that were able to predict the immune status of patients, and which may serve as potential targets for the treatment of breast cancer. We also aimed to identify microRNAs that may regulate the expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30607158
DOI: 10.4048/jbc.2018.21.e60

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-195/miR-497 RegulateCD274Expression of Immune Regulatory Ligands in Triple-Negative Breast CancerPMID 30607158Read ↗

Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancerSemantic proximity Read ↗

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.Semantic proximity Read ↗

miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.Semantic proximity Read ↗

Expression of long non‐coding RNA ENSG 00000226738 (Lnc KLHDC 7B) is enriched in the immunomodulatory triple‐negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell deathSemantic proximity Read ↗

Integrative analysis of mRNA and miRNA proﬁles identifies miR-193 and miR-210 as potential regulatory biomarkers in diﬀerent molecular subtypes of breast cancerSemantic proximity Read ↗

Eribulin represses effector T cell differentiation and enhances T cell-mediated anti-tumor activity to triple negative breast cancer cells through the facilitation of CD8+ T cell proliferationSemantic proximity Read ↗

High expression of TLR3 in triple-negative breast cancer predicts better prognosis —data from the Fudan University Shanghai Cancer Center cohort and tissue microarraysSemantic proximity Read ↗

PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?Semantic proximity Read ↗

PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarkerSemantic proximity Read ↗

Coordinated regulation of WNT/β-catenin, c-Met, and Integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traitsSemantic proximity Read ↗

Upregulation of CD271 Transcriptome in Breast Cancer Promotes Cell Survival via NFκB PathwaySemantic proximity Read ↗

The expression, function, and clinical relevance of B7 family members in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.